Skip to main content

Confidence, performance, and accuracy of self-assessment of social cognition: a comparison of schizophrenia patients and healthy controls

January 1, 2019
Impairments in self-assessment in schizophrenia have been shown to have functional and clinical implications. Prior studies have suggested that overconfidence can be associated with poorer cognitive performance in people with schizophrenia, and that reduced awareness of performance may be associated with disability…read more. Jones MT, Deckler E, Laurrari C, Jarskog...

Depression and reduced emotional experience in schizophrenia: correlations with self-reported and informant rated everyday social functioning

January 1, 2019
Negative symptoms and depression persist in one third of patients with schizophrenia. Previous studies suggested that depression has more impact on self-perceived compared to observer-rated social functions. Reduced emotional experience, a subdomain of negative symptoms, predicts social functioning deficits, although its role in self-assessment is unclear. We examined depression and...

Depression and reduced emotional experience in schizophrenia: correlations with self-reported and informant rated everyday social functioning

January 1, 2019
Negative symptoms and depression persist in one third of patients with schizophrenia. Previous studies suggested that depression has more impact on self-perceived compared to observer-rated social functions. Reduced emotional experience, a subdomain of negative symptoms, predicts social functioning deficits, although its role in self-assessment is unclear. We examined depression and...

Autism symptoms, depression, and active social avoidance in schizophrenia: association with self-reports and informant assessments of everyday functioning

January 1, 2019
Participants with schizophrenia self-reported their everyday functioning and social cognitive ability as well as their depression. All were rated with the PANSS and a separate rater generated all-sources ratings of everyday functioning and social cognitive ability. Correlations between self-reported everyday functioning and social cognitive ability, ratings of everyday functioning and...

Predictors of social functioning in patients with higher and lower levels of reduced emotional experience: social cognition, social competence, and symptom severity

January 1, 2019
Deficits in social functioning in schizophrenia are primarily predicted by negative symptoms, social cognition deficits, and social skills deficits. Here we examine those predictive variables across variations in the severity of reduced emotional experience. We hypothesized that in patients with high symptom severity, factors such as social cognition would have...

Effects of oxytocin on empathy, introspective accuracy, and social symptoms in schizophrenia: a 12-week twice-daily randomized controlled trial

January 1, 2019
The effects of intranasal oxytocin, a neuropeptide involved in prosocial behavior and modulation of neural networks underlying social cognition and emotion regulation, have been studied in schizophrenia. We tested the hypothesis that twice-daily intranasal oxytocin administered for 12-weeks would improve tertiary and exploratory outcomes of self-reported social symptoms, empathy and...

Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia

January 1, 2019
Patients with tardive dyskinesia who completed a 12 week, phase 3, placebo-controlled trials were eligible to enter this open-label, single-arm study. The open-label study consisted of a 6 week dose-escalation phase and a long-term maintenance phase of 106 weeks. The objective was to evaluate the long-term safety and efficacy of...

White matter development in infants at risk for schizophrenia

January 1, 2019
Schizophrenia is considered a neurodevelopmental disorder with a pathophysiology that likely begins long before the onset of clinical symptoms. White matter abnormalities have been observed in schizophrenia and we hypothesized that the first 2 years of life is a period in which white matter abnormalities associated with schizophrenia risk may...

Targeting reduced neural oscillations in patients with schizophrenia by transcranial alternating current stimulation

January 1, 2019
Transcranial alternating current stimulation (tACS) modulates endogenous neural oscillations in healthy human participants by the application of a low-amplitude electrical current with a periodic stimulation waveform. Yet, it is unclear if tACS can modulate and restore neural oscillations that are reduced in patients with psychiatric illnesses such as schizophrenia. Here,...

Director’s Message

December 17, 2018
It has been exciting and busy at the Center. We continue to grow our services to serve more individuals with serious mental illness in the Triangle and across the State. Thava Mahadevan, MS, our operations director, just received a new $2.4M federal  grant that will provide coordinated care for individuals...

Center receives $2.4 million SAMHSA grant to address homelessness and provide comprehensive behavioral (mental health) care

December 17, 2018
The UNC Center for Excellence in Community Mental Health has received a $2.4 million grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) to address homelessness and provide comprehensive behavioral (mental health) care and other services for individuals living with serious mental illnesses who are experiencing or who...

The Center is expanding its mobile health clinic through a collaboration with the Foundation of Hope

December 17, 2018
The UNC Center for Excellence in Community Mental Health and the UNC School of Nursing will collaborate with the Foundation of Hope to expand the Center’s mobile clinic, UNC Wellness on Wheels (W.O.W) program, and provide services two days a week to individuals with serious mental health challenges who live...